Cover Image

Prioritizing Public Health : The FDA's Role in the Generic Drug Marketplace : Special Hearing.

Bibliographic Details
Format:	Government Document eBook
Language:	English
Published:	Bethesda, Md. : ProQuest, 2016.
Subjects:	United States. > Food and Drug Administration. Generic drugs > Law and legislation > United States. User charges > Law and legislation > United States.
Online Access:	Electronic resource (PDF)

Similar Items

Generic Drug User Fee Amendments : Accelerating Patient Access to Generic Drugs.
Published: (2016)

Proposed FDA user fee acts : Generic Drug User Fee Amendments of 2012 (GDUFA) and Biosimilar User Fee Act of 2012 (BSUFA) /
by: Thaul, Susan, et al.
Published: (2019)

Committee prints on administration legislative proposals on the Animal Drug User Fee Act Amendments of 2008 and the Animal Generic Drug User Fee Act of 2008 : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, June 5, 2008.
Published: (2008)

Generic drugs and GDUFA reauthorization : in brief /
by: Johnson, Judith A. (Judith Ann), 1957-
Published: (2018)

Reauthorization of PDUFA : What It Means for Jobs, Innovation, and Patients.
Published: (2012)

Prescription Drug User Fee Act (PDUFA) : 2017 reauthorization as PDUFA VI /
by: Dabrowska, Agata, et al.
Published: (2018)

Prescription Drug User Fee Act (PDUFA) : 2012 reauthorization as PDUFA V /
by: Thaul, Susan
Published: (2019)

Examining FDA's Generic Drug and Biosimilar User Fee Programs.
Published: (2017)

FDA User Fee Agreements : Improving Medical Product Regulation and Innovation for Patients.
Published: (2017)

Reauthorization of MDUFA : What It Means for Jobs, Innovation, and Patients.
Published: (2012)

Examining FDA's Prescription Drug User Fee Program.
Published: (2017)

Reviewing FDA's Implementation of FDASIA.
Published: (2013)

FDA Reauthorization Act of 2017 (FDARA, P.L. 115-52) /
by: Sarata, Amanda K.
Published: (2018)

Examining FDA's Prescription Drug User Fee program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
Published: (2018)

Examining Concerns Regarding FDA's Proposed Changes to Generic Drug Labeling.
Published: (2014)

Reauthorization of animal drug user fees : ADUFA and AGDUFA : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, April 9, 2013.
Published: (2013)

Animal Generic Drug User Fee Act of 2008 : report (to accompany H.R. 6433) (including cost estimate of the Congressional Budget Office).
Published: (2008)

Committee prints on administration legislative proposals on the Animal Drug User Fee Act Amendments of 2008 and the Animal Generic Drug User Fee Act of 2008 : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, June 5, 2008.
Published: (2008)

The Food and Drug Administration Safety and Innovation Act (FDASIA, P.L. 112-144) /
by: Thaul, Susan
Published: (2018)

Antitrust Concerns and the FDA Approval Process.
Published: (2017)

Expanding the use of generic drugs.
Published: (2010)

H.R. 339, the Northern Mariana Islands Economic Expansion Act.
Published: (2017)

Developments in the Prescription Drug Market : Oversight.
Published: (2016)

The generic drug user fee amendments (GDUFA) : background and reauthorization /
by: Bodie, Agata
Published: (2021)

FDA Risk Evaluation and Mitigation Strategies (REMS) : description and effect on generic drug development /
by: Dabrowska, Agata
Published: (2018)

Authorized generics : an interim report.
Published: (2009)

Reauthorization of Animal Drug User Fees : ADUFA and AGDUFA.
Published: (2013)

H.R. 985, Concrete Masonry Products Research, Education, and Promotion Act of 2015.
Published: (2015)

Animal Drug User Fee Agreements : Advancing Animal Health for the Public.
Published: (2013)

FDA in the twenty-first century : the challenges of regulating drugs and new technologies /
Published: (2015)

Medical Device User Fee and Modernization Act (MDUFMA) reauthorization /
by: Williams, Erin D.
Published: (2019)

Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017.
Published: (2018)

Examining How the Dodd-Frank Act Hampers Home Ownership.
Published: (2013)

FDA User Fees 2012 : How Innovation Helps Patients and Jobs.
Published: (2012)

Risk evaluation and mitigation strategies (REMS) and generic drugs /
by: Dabrowska, Agata
Published: (2018)

FDA's generic drug application policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988.
Published: (1989)

How FDA approves drugs and regulates their safety and effectiveness /
by: Dabrowska, Agata
Published: (2018)

Examining the Impact of Voluntary Restricted Distribution Systems in the Pharmaceutical Supply Chain.
Published: (2017)

FDA User Fee Agreements : Strengthening FDA and the Medical Products Industry for the Benefit of Patients.
Published: (2012)

The FDA medical device user fee program : MDUFA IV reauthorization /
by: Johnson, Judith A. (Judith Ann), 1957-
Published: (2018)